GET THE APP

Pediatrics & Therapeutics

Pediatrics & Therapeutics
Open Access

ISSN: 2161-0665

+44 1478 350008

Roman Crazzolara

Department of Paediatrics, Division for Haematology and Oncology, Medical University Innsbruck, Innsbruck, Austria

Publications
  • Research Article   
    Omega-3 Fatty Acid Supplementation as Therapeutic Option for Children with ADHD-Symptoms
    Author(s): Regina Theresa Hauser, Judith Erler, Gabriele Kropshofer, Roman Crazzolara, Miriam Michel and Christina Salvador*

    Background: Globally, the number of children with Attention/Hyperactivity Disorder (ADHD) counts approximately 3.4%. One of the most common ways of treatment is the intake of psychostimulants. Hyperactive children can show significantly lower serum levels of omega-3 fatty acids, or even an acceleration of omega-3 fatty acid catabolism, compared to control groups without hyperactivity disorder. Especially Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) are essential for children’s brain growth and function, thus their lack is assumed to influence the progress of the disorder negatively. Methods: A PubMed search was conducted with key terms “omega-3 fatty acids” OR “children” OR “attention/ hyperactivity disorder”. The search strategy included meta-analyses, randomized controlled trials, cli.. View More»
    DOI: 10.35841/2161-0665.22.12.457

    Abstract HTML PDF

Top